|
General Information
|
|
|
Product
|
TDRKH Peptide
|
|
Description
|
Antigenic Blocking Peptide Tudor and KH domain-containing protein (TDRKH)
|
|
Verified Applications
|
Immunocompeition, Immunodepletion
|
|
Peptide Description
|
Synthetic Peptide
|
|
Accession #
|
Gen Bank: AF227192.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q9Y2W6
|
|
Overview
|
Participates in the primary piRNA biogenesis pathway and is required during spermatogenesis to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. The piRNA metabolic process mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons.
|
|
Molecular Function
|
RNA binding
|
|
Subcellular Location
|
cytoplasm, mitochondrion
|
|
Alternative Nomenclature
|
2700091C21Rik antibody
Putative RNA binding protein antibody
RGD1311196 antibody
RP11-98D18.8 antibody
TDRD2 antibody
TDRD7 antibody
Tudor and KH domain-containing protein antibody
Tudor domain-containing protein 2 antibody
|
| |
|
TDRKH Antibody
TDRKH Antibody FITC
TDRKH Antibody BIOTIN
TDRKH Positive Control
